Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BIOLASE Inc (NASDAQ:BIOL)

1.12
Delayed Data
As of 10:00am ET
 -0.0515 / -4.40%
Today’s Change
0.60
Today|||52-Week Range
1.84
+32.98%
Year-to-Date
No recent news for BIOLASE Inc.

Today’s Trading

Previous close1.17
Today’s open1.16
Day’s range1.00 - 1.17
Volume2,402
Average volume (3 months)74,901
Market cap$68.2M
Dividend yield--
Data as of 10:00am ET, 07/01/2016

Growth & Valuation

Earnings growth (last year)+22.22%
Earnings growth (this year)+60.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+1.62%
P/E ratioNM
Price/Sales1.02
Price/Book2.50

Competitors

 Today’s
change
Today’s
% change
MLSSMilestone Scientific...-0.10-3.57%
PDEXPro-Dex Inc-0.12-2.16%
ALGNAlign Technology Inc+1.03+1.28%
XRAYDentsply Sirona Inc+0.10+0.16%
Data as of 10:18am ET, 07/01/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$48.1M
Annual profit (last year)-$20.3M
Net profit margin-42.15%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Harold C. Flynn
Vice President-
Operations
Richard R. Whipp
Corporate headquarters
Irvine, California

Forecasts

Partner Offers

Search for Jobs